Links To The CDC Resources On RSV

See also Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season. Distributed via the CDC Health Alert Network
October 23, 2023, 3:30 PM ET

Today, I reviewed and link to the Centers For Disease Control And Prevention (CDC) resources on Respiratory Syncytial Virus (RSV).

Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are available to protect older adults from severe RSV. Preventive options are available to protect infants and young children from severe RSV.

Symptoms & Care

Preventing RSV


All that follows is from the above resource.

RSV Home

This entry was posted in Centers For Disease Control And Prevention, Infectious Diseases. Bookmark the permalink.